Literature DB >> 32158338

Brain Abscess as a Rare Complication of Primary Extranodal Nasal-type Natural Killer/T-cell Lymphoma.

Nobuo Ohta1, Takayoshi Waki2, Tsukasa Ito2, Yusuke Suzuki2, Seiji Kakehata2, Masaru Aoyagi2.   

Abstract

We present the case of a 58-year-old Japanese woman with a natural killer T (NK/T)-cell lymphoma complicated by brain abscess. NK/T-cell lymphomas represent a rare type of lymphoma derived from either activated NK cells or, rarely, cytotoxic T cells. They are aggressive Epstein-Barr virus (EBV)-associated lymphomas that involve mainly the nasal cavity. Brain abscess associated with primary extranodal nasal-type NK/T-cell lymphoma is extremely uncommon: to our knowledge, this is the first reported case of this lymphoma with brain abscess as the initial clinical manifestation. Endoscopic surgery was performed for definitive diagnosis under intraoperative navigation system. Chemotherapy followed by radiotherapy was performed and was effective: 72 months later the tumor has not recurred. Recommendations of endoscopic management for diagnosis and treatment of this rare neoplasm are discussed. ©2020 Tottori University Medical Press.

Entities:  

Keywords:  brain abscess; natural killer/T-cell lymphoma

Year:  2020        PMID: 32158338      PMCID: PMC7028533          DOI: 10.33160/yam.2020.02.010

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.641


  8 in total

1.  Extranodal NK/T-cell lymphoma, nasal type extensively involving the bone marrow.

Authors:  Sherif A Rezk; Qin Huang
Journal:  Int J Clin Exp Pathol       Date:  2011-10-10

2.  Natural killer/T-cell lymphoma of nasal type with intraocular involvement: case report.

Authors:  Eun Ji Lee; Tae Wan Kim; Jang Won Heo; Hyeong Gon Yu; Hum Chung
Journal:  Eur J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 2.597

3.  Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: a case report.

Authors:  Vesna Kaluza; Dinesh S Rao; Jonathan W Said; Sven de Vos
Journal:  Hum Pathol       Date:  2006-06       Impact factor: 3.466

Review 4.  NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.

Authors:  Ritsuro Suzuki
Journal:  Curr Oncol Rep       Date:  2012-10       Impact factor: 5.075

Review 5.  Practical management of natural killer/T-cell lymphoma.

Authors:  Eric Tse; Yok-Lam Kwong
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

6.  Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type.

Authors:  Yoshinori Ito; Hiroshi Kimura; Yoshinobu Maeda; Chizuko Hashimoto; Fumihiro Ishida; Koji Izutsu; Noriyasu Fukushima; Yasushi Isobe; Jun Takizawa; Yuichi Hasegawa; Hajime Kobayashi; Seiichi Okamura; Hikaru Kobayashi; Motoko Yamaguchi; Junji Suzumiya; Rie Hyo; Shigeo Nakamura; Keisei Kawa; Kazuo Oshimi; Ritsuro Suzuki
Journal:  Clin Cancer Res       Date:  2012-06-06       Impact factor: 12.531

Review 7.  Current and future management of NK/T-cell lymphoma based on clinical trials.

Authors:  Motoko Yamaguchi
Journal:  Int J Hematol       Date:  2012-10-17       Impact factor: 2.490

Review 8.  Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.

Authors:  Motoko Yamaguchi; Ritsuro Suzuki; Masahiko Oguchi
Journal:  Blood       Date:  2018-03-30       Impact factor: 22.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.